Vicarious Surgical Inc. (RBOT)
USD 12.46
(-10.1%)
USD 12.46
(-10.1%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -69.19 Million USD | -0.21% |
| 2022 | 7.29 Million USD | -103.98% |
| 2021 | -34.8 Million USD | -203.22% |
| 2020 | -161.17 Thousand USD | -31.37% |
| 2019 | -9.67 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -17.18 Million USD | 10.92% |
| 2024 Q1 | -15.58 Million USD | -31.17% |
| 2023 FY | - USD | -0.21% |
| 2023 Q4 | -15.01 Million USD | 29.67% |
| 2023 Q3 | -21.35 Million USD | -4.59% |
| 2023 Q1 | -20.84 Million USD | -5.38% |
| 2023 Q2 | -20.41 Million USD | 2.05% |
| 2022 Q3 | -21.66 Million USD | -15.02% |
| 2022 Q4 | -19.77 Million USD | 8.72% |
| 2022 FY | - USD | -103.98% |
| 2022 Q2 | -18.83 Million USD | -4.74% |
| 2022 Q1 | -17.98 Million USD | 0.91% |
| 2021 Q1 | -5.18 Million USD | -38.78% |
| 2021 FY | - USD | -203.22% |
| 2021 Q4 | -18.15 Million USD | -114.16% |
| 2021 Q3 | -8.47 Million USD | -28.21% |
| 2021 Q2 | -6.61 Million USD | -27.4% |
| 2020 Q4 | -3.73 Million USD | -11.95% |
| 2020 Q1 | -2.75 Million USD | 0.0% |
| 2020 Q3 | -3.34 Million USD | -10.23% |
| 2020 FY | - USD | -31.37% |
| 2020 Q2 | -3.03 Million USD | -9.9% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 100.661% |
| Allurion Technologies Inc. | -69.03 Million USD | -0.233% |
| Artivion, Inc. | 38.14 Million USD | 281.406% |
| Avanos Medical, Inc. | 53.2 Million USD | 230.06% |
| Butterfly Network, Inc. | -124.84 Million USD | 44.577% |
| Butterfly Network, Inc. | -124.84 Million USD | 44.577% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 88.625% |
| Boston Scientific Corporation | 3.45 Billion USD | 102.004% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | -366.316% |
| CONMED Corporation | 182.18 Million USD | 137.979% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | 103.914% |
| Paragon 28, Inc. | -36.61 Million USD | -88.977% |
| Glaukos Corporation | -82.11 Million USD | 15.739% |
| Globus Medical, Inc. | 418.23 Million USD | 116.544% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | -305.58% |
| Integer Holdings Corporation | 282.05 Million USD | 124.531% |
| Medtronic plc | 9.05 Billion USD | 100.764% |
| Nevro Corp. | -78.31 Million USD | 11.643% |
| Owlet, Inc. | -27.48 Million USD | -151.708% |
| Penumbra, Inc. | 111.99 Million USD | 161.781% |
| Smith & Nephew plc | 979 Million USD | 107.068% |
| Sonendo, Inc. | -54.76 Million USD | -26.337% |
| STERIS plc | 1.41 Billion USD | 104.899% |
| Stryker Corporation | 5.16 Billion USD | 101.341% |
| Vapotherm, Inc. | -34.35 Million USD | -101.391% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | 102.825% |